Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)

ConclusionThis model can be used to evaluate strategies for the allocation of adjuvant chemotherapy in stage II CC patients. In future studies, the model will be used to estimate population-level long-term health gain and cost-effectiveness of biomarker-based selection strategies.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research